Wolverine Trading
ACOR

Wolverine Trading’s Acorda Therapeutics ACOR Stock Holding History

Wolverine Trading’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-109
Closed -$39K – 5391
2019
Q3 		$39K Buy
+109
New +$59.3K ﹤0.01% 4096
2017
Q4 		– Sell
-254
Closed -$721K – 5684
2017
Q3 		$721K Buy
+254
New +$669K ﹤0.01% 2220
2017
Q2 		– Sell
-100
Closed -$198K – 5173
2017
Q1 		$321K Buy
+100
New +$288K ﹤0.01% 2941
2016
Q3 		– Sell
-127
Closed -$379K – 5249
2016
Q2 		$387K Buy
+127
New +$413K ﹤0.01% 2505

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wolverine Trading's ACOR Position: Q4 2019 in Review

Wolverine Trading sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 109 shares — an estimated $39K sold.

Wolverine Trading first reported a position in ACOR in Q2 2016 and held it in 4 quarters. The position peaked at $721K in Q3 2017. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Wolverine Trading reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Wolverine Trading sold 109 Acorda Therapeutics shares in Q4 2019, an estimated $39K.
  • Wolverine Trading first reported a position in Acorda Therapeutics in Q2 2016 and held it in 4 quarters.
  • Wolverine Trading's Acorda Therapeutics position peaked at $721K in Q3 2017.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.